THE DIFFERENCES BETWEEN PEOPLE UNDER THE AGE OF 60 AND OVER THE AGE OF 60 IN COVID-19 VACCINATION RATES AND VACCINE BRAND PERCEPTION

Abstract

This article deals with differences in users’ perception towards COVID-19 vaccination and towards individual COVID-19 vaccine brands. Since COVID-19 is much more dangerous to the elderly population, this article deals with differences between those under the age of 60 and those over the age of 60. The results show that there are some differences between those two groups. For the group of people under the age of 60, the duration of protection is more important (39%), while the brand of vaccine is less important (25%). In contrast, the vaccine brand is of much greater importance (34%) and the duration of protection less important (25%) for the group of people over the age of 60. The study also showed differences in relation to individual brands of COVID-19 vaccines, with both groups preferring Pfizer to other brands, which is not surprising, since there was the least amount of negative media coverage about Pfizer, especially compared to AstraZeneca. The vaccine brand is surprisingly more important to those over the age of 60 than to those under the age of 60, while the effectiveness of the vaccine is equally important for both groups and both groups are equally sensitive to duration and side effects of the vaccine.